According to Technavio, the global travel vaccines market will grow by USD 3.97 billion from 2024 to 2028, at a CAGR of almost 8.64 percent during the forecast period.
The Travel Vaccines Market in North America is expected to dominate the global scene due to the presence of organisations like the Pan American Health Organisation and the requirement of proof of vaccination for international travel. The market caters to first-time travellers and regular vacationers, offering vaccines such as BOOSTRIX, INFANRIX, Pediarix, BEXSERO, MENVEO, and influenza vaccines. With the increasing prevalence of diseases like influenza, rabies, typhoid, measles, and mumps, travel clinics have become essential for ensuring complete immunisation before overseas travel.
New vaccines, including those for dengue fever, hepatitis B, and measles, mumps, and rubella (MMR), are continually being introduced, incurring substantial costs for consultation fees and administration charges for multiple doses. While vaccines offer immunity against various microbes and pathogenic organisms, it is essential to consider disease type, likelihood of illness, and health hazards before use. Safety, side effects, and dosages are critical factors to consider when choosing travel vaccinations. Companies like Takeda, Dyanavax, and those producing bio-based drugs and antibodies are at the forefront of developing innovative travel vaccine solutions.
The travel vaccines market is influenced by various factors, including demographics and disease prevalence. Migrants, particularly those from younger age groups, have lower vaccination rates, increasing the risk of vaccine-preventable diseases in host countries. Key vaccines include those for hepatitis B, Dengue fever, and yellow fever. Novel technologies like mRNA vaccines and recombinant DNA technology are driving industry gains. Travelers should be aware of potential side effects, dosages, and safety concerns when using vaccines for diseases like cholera, hepatitis B, and yellow fever.
The travel vaccines market is influenced by various factors, including demographics and disease prevalence. Migrants, particularly those from younger age groups, have lower vaccination rates, increasing the risk of vaccine-preventable diseases in host countries. Key vaccines include those for hepatitis B, Dengue fever, and yellow fever. Novel technologies like mRNA vaccines and recombinant DNA technology are driving industry gains. Travelers should be aware of potential side effects, dosages, and safety concerns when using vaccines for diseases like cholera, hepatitis B, and yellow fever.
To read more global news, click here.
